Generic alternative to EpiPen released amid allergy treatment shortage

(By Alia Paavola for Becker’s Hospital Review)

Sandoz, a generics and biosimilar unit of Novartis, will make its generic epinephrine shots immediately available for sale in U.S. retail pharmacies as a shortage of Mylan’s lifesaving allergy treatment EpiPen drags on.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply